Takeda joins hot molecular glue market with $1.2B deal—AstraZeneca pays $19M to Harbour BioMed's Nona for preclinical cancer antibodies —Pfizer expands cost cuts with new $1.5B target --http://bit.ly/w28kSd #takeda #molecularglue #astrazeneca #pfizer #layoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Biogen sees flat 2024 sales, pick up in Alzheimer's drug demand—BMS signs $674M biobucks pact with Roivant's VantAI for molecular glues — Medtech layoffs continue in 2024--http://bit.ly/w28kSd #earnings #biogen #alzheimers #bristolmyerssquibb #biobucks #molecularglue #layoffs #medtech #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

The lysosomal degraders

#PROTAC +derivatives

An update on Research & Commercialization of #MolecularGlue for targeted protein degradation

"LYTACs, ATACs, AbTACs, KineTACs, PROTABs, AUTACs, ATTECs and AUTOTACs"

Ken Garber Nature Biotech 2022
https://www.nature.com/articles/s41587-022-01594-7